On Monday, SELLAS Life Sciences Group Inc (NASDAQ: SLS) opened lower -6.57% from the last session, before settling in for the closing price of $1.37. Price fluctuations for SLS have ranged from $0.66 to $1.84 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 28.29%. Company’s average yearly earnings per share was noted 59.95% at the time writing. With a float of $76.59 million, this company’s outstanding shares have now reached $78.58 million.
Let’s determine the extent of company efficiency that accounts for 16 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
SELLAS Life Sciences Group Inc (SLS) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of SELLAS Life Sciences Group Inc is 2.53%, while institutional ownership is 6.89%.
SELLAS Life Sciences Group Inc (SLS) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 59.95% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.48% during the next five years compared to 61.44% growth over the previous five years of trading.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
Check out the current performance indicators for SELLAS Life Sciences Group Inc (SLS). In the past quarter, the stock posted a quick ratio of 2.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.70, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.45 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
Looking closely at SELLAS Life Sciences Group Inc (NASDAQ: SLS), its last 5-days average volume was 2.31 million, which is a drop from its year-to-date volume of 4.6 million. As of the previous 9 days, the stock’s Stochastic %D was 38.07%. Additionally, its Average True Range was 0.19.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 47.57%, which indicates a significant increase from 43.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 204.16% in the past 14 days, which was higher than the 96.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0966, while its 200-day Moving Average is $1.2203. However, in the short run, SELLAS Life Sciences Group Inc’s stock first resistance to watch stands at $1.3683. Second resistance stands at $1.4567. The third major resistance level sits at $1.5333. If the price goes on to break the first support level at $1.2033, it is likely to go to the next support level at $1.1267. Now, if the price goes above the second support level, the third support stands at $1.0383.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Key Stats
There are currently 70,382K shares outstanding in the company with a market cap of 100.59 million. Presently, the company’s annual sales total 0 K according to its annual income of -37,340 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -7,110 K.
